Michelle Haber
- January 4, 2024
- Oncologist
Quick Facts
Full Name | Michelle Haber |
Occupation | Oncologist |
Date Of Birth | Oct 18, 1956(1956-10-18) |
Age | 68 |
Birthplace | Liverpool |
Country | Australia |
Horoscope | Libra |
Michelle Haber Biography
Name | Michelle Haber |
Birthday | Oct 18 |
Birth Year | 1956 |
Place Of Birth | Liverpool |
Birth Country | Australia |
Birth Sign | Libra |
Michelle Haber is one of the most popular and richest Oncologist who was born on October 18, 1956 in Liverpool, Australia. Michelle Haber AM, born 18 October 1956, is an Australian cancer researcher.
Haber was made a Member of Australia’s Order of Merit (AM) in 2007 for her service to science and education in childhood cancer research. Financial Review’s Boss Magazine also listed Haber as one of Australia’s 25 True Leaders. Haber received the University of New South Wales DSc (Honoris Causa), in 2008 for her outstanding service to cancer research. Numerous awards have been presented to Haber for excellence in research, including the NSW Science & Engineering Award, Biomedical Sciences (2011). She was also one of four finalists for Australian Of The Year. Haber, along with her long-time collaborators Norris and Marshall, received the Cancer Institute NSW Premier’s Award of Excellence in Translational Cancer Research in 2012. She was also awarded a National Health and Medical Research Council’s Ten of the Best Award. She was featured in an article in The Lancet in 2013 with Norris Marshall. She was a finalist for the 2013 Australian Museum Eureka Prize for Medical Research Translation and she received the NSW Premier’s Award for Outstanding Cancer Researcher in 2014. Haber was made a Fellow of Australia’s Academy of Health and Medical Sciences (March 2015).
Haber’s early studies were amongst the first characterizing the complex molecular mechanisms underlying therapy-related drug resistance. With her collaborators, she identified the relationship between high expression of multidrug transporter gene MRP1, and the malignant phenotype of neuroblastoma and poor clinical outcome. These studies provided the first definitive demonstration of clinical relevance of the MRP1 gene in solid tumours, resulting in a large international clinical study which confirmed the independent prognostic significance of MRP1 expression in neuroblastoma and established MRP1 inhibition as a potential new treatment for this disease.
Under her leadership Children’s Cancer Institute, now located in the UNSW Lowy Cancer Research Centre, has tripled in size and grown from a little known group to become the largest children’s cancer research facility in the region.
Haber is a long-term member of the International Neuroblastoma Risk Group Committee, which makes recommendations regarding standardised protocols and best practice for identifying/utilising prognostic indicators for neuroblastoma treatment risk assessment. Haber was the President of the Advances in Neuroblastoma Research Association from 2010 to 2012. Haber was also instrumental in the establishment of Kids Cancer Alliance. He currently sits on its executive management committee. Haber is the convenor of the 2016 Advances in Neuroblastoma Research conference in Cairns (Australia), which is one of the most important international conferences on childhood cancer.
Michelle Haber Net Worth
Net Worth | $5 Million |
Source Of Income | Oncologist |
House | Living in own house. |
Michelle Haber is one of the richest Oncologist from Australia. According to our analysis, Wikipedia, Forbes & Business Insider, Michelle Haber 's net worth $5 Million. (Last Update: December 11, 2023)
Haber was educated at Mount Scopus Memorial College in Melbourne, and then, after her family moved to Sydney in 1973, she attended Moriah College. She received a University Medal for her clinical psychology degree from the University of New South Wales. In 1984, she received her PhD from the School of Pathology of the University of New South Wales. Her thesis was entitled “Structural analysis using BD-cellulose chromatography of mammalian genome during repair, replication and decay”. In 2008, she was conferred the Doctor of Science honoris causa degree by the University of New South Wales.
Haber was a visiting researcher at Hadassah Medical Centre in Jerusalem for three months during her PhD. Her first postdoctoral job was at Children’s Leukaemia & Cancer Research Unit. This unit was a precursor of Children’s Cancer Institute, which was located at Randwick’s Prince of Wales Children’s Hospital. She joined the hospital in 1984 as a staff scientist. In 1992, she was promoted to Senior Research Fellow, Principal Research Fellow, Director in 2000, and Executive Director in 2003. Haber is also a Professor at the University of New South Wales’ Faculty of Medicine.
Haber and her collaborators have also identified the role of ATP-binding cassette transporter genes (ABC transporters) in neuroblastoma biology, demonstrating that their expression predicts for poor clinical outcome in neuroblastoma but, unexpectedly, this phenomenon was not due to the ABC proteins’ role in drug transport, but through an independent pathway that influences fundamental aspects of tumour biology. A further study on ovarian cancer and ABCA1 has extended the discovery to common adult cancers.
Height, Weight & Body Measurements
Michelle Haber height Not available right now. Michelle weight Not Known & body measurements will update soon.
Who is Michelle Haber Dating?
According to our records, Michelle Haber is possibily single & has not been previously engaged. As of December 1, 2023, Michelle Haber’s is not dating anyone.
Relationships Record : We have no records of past relationships for Michelle Haber. You may help us to build the dating records for Michelle Haber!
Facts & Trivia
Michelle Ranked on the list of most popular Oncologist. Also ranked in the elit list of famous people born in Australia. Michelle Haber celebrates birthday on October 18 of every year.